---
title: "CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial  | CERO Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282689435.md"
description: "CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial | CERO Stock News"
datetime: "2026-04-14T04:15:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282689435.md)
  - [en](https://longbridge.com/en/news/282689435.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282689435.md)
generator: "portal-rs"
---

# CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial  | CERO Stock News

CERo Therapeutics Doses Third Patient in Cohort 2 of Phase 1 CER-1236 Trial | CERO Stock News

### Related Stocks

- [CERO.US](https://longbridge.com/en/quote/CERO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [CEROW.US](https://longbridge.com/en/quote/CEROW.US.md)

## Related News & Research

- [SRX Global buys senior secured debt in CERo Therapeutics Holdings](https://longbridge.com/en/news/297509635.md)
- [CERo Therapeutics Secures Up to $11.67 Million SRX Financing, Consolidates $5.67 Million Debt](https://longbridge.com/en/news/297561416.md)
- [Cero Therapeutics signs SRX Global secured note for up to $11.67 million](https://longbridge.com/en/news/297560953.md)
- [SRX Global sells 3,579 Series C preferred shares in private placement valued at $2.86 million](https://longbridge.com/en/news/297369039.md)
- [“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z](https://longbridge.com/en/news/297407072.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**